RRM1 gene expression in peripheral blood is predictive of shorter survival in Chinese patients with advanced non-small-cell lung cancer treated by gemcitabine and platinum

Journal of Zhejiang University: Science B

Volumn 12, Issue 3, 2011, Pages 174-179

  Wang, Lin Run ^a   Zhang, Guo Bing ^a   Chen, Jian ^a   Li, Jun ^a   Li, Ming Wei ^a   Xu, Nong ^a   Wang, Yang ^a   Shen Tu, Jian Zhong ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Breast cancer susceptibility gene 1 (BRCA1); Gemcitabine; Gene expression; Non small cell lung cancer (NSCLC); Ribonucleotide reductase M1 (RRM1)

Indexed keywords

BRCA1 PROTEIN; CARBOPLATIN; GEFITINIB; GEMCITABINE; RIBONUCLEOTIDE REDUCTASE; RIBONUCLEOTIDE REDUCTASE M1; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHINESE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; DRUG RESPONSE; DRUG WITHDRAWAL; FEMALE; GENE EXPRESSION PROFILING; HUMAN; KAPLAN MEIER METHOD; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; OVERALL SURVIVAL; PERIPHERAL CIRCULATION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL TIME; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BRCA1 PROTEIN; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DEOXYCYTIDINE; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BRCA1; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEINS;

EID: 79954507728     PISSN: 16731581     EISSN: 18621783     Source Type: Journal    
DOI: 10.1631/jzus.B1000197     Document Type: Article

References (16)

1. P. Ceppi M. Volante S. Novello I. Rapa K.D. Danenberg P.V. Danenberg A. Cambieri G. Selvaggi S. Saviozzi R. Calogero, et al. 2006 ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine Ann. Oncol. 17 12 1818 1825 16980606 10.1093/annonc/mdl300 1:STN:280:DC%2BD28jhtlWhug%3D%3D (Pubitemid 44884058)
2. J.D. Davidson L. Ma M. Flagella S. Geeganage L.M. Gelbert C.A. Slapak 2004 An increase in the expression of ribonucleotide reductase large subunit 1 is associated with gemcitabine resistance in non-small cell lung cancer cell lines Cancer Res. 64 11 3761 3766 15172981 10.1158/0008-5472.CAN-03-3363 1:CAS:528:DC%2BD2cXksVKgurk%3D (Pubitemid 38697284)
3. S. Dong A.L. Guo Z.H. Chen Z. Wang X.C. Zhang Y. Huang Z. Xie H.H. Yan H. Cheng Y.L. Wu 2010 RRM1 single nucleotide polymorphism -37C→A correlates with progression-free survival in NSCLC patients after gemcitabine-based chemotherapy J. Hematol. Oncol. 3 1 10 20226083 10.1186/1756-8722-3-10
4. A. Gautam Z.R. Li G. Bepler 2003 RRM1-induced metastasis suppression through PTEN-regulated pathways Oncogene 22 14 2135 2142 12687015 10.1038/sj.onc.1206232 1:CAS:528:DC%2BD3sXislyitbo%3D (Pubitemid 36539563)
5. Y.G. Goan B. Zhou E. Hu S. Mi Y. Yen 1999 Overexpression of ribonucleotide reductase as a mechanism of resistance to 2,2- difluorodeoxycytidine in the human KB cancer cell line Cancer Res. 59 17 4204 4207 10485455 1:CAS:528:DyaK1MXlvVSnu7o%3D (Pubitemid 29418726)
6. D. Isla C. Sarries R. Rosell G. Alonso M. Domine M. Taron G. Lopez-Vivanco C. Camps M. Botia L. Nunez, et al. 2004 Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer Ann. Oncol. 15 8 1194 1203 15277258 10.1093/annonc/mdh319 1:STN:280:DC%2BD2cznt1Wmtw%3D%3D (Pubitemid 39199306)
7. A. Jemal R. Siegel E. Ward T. Murray J. Xu M.J. Thun 2007 Cancer statistics, 2007 CA Cancer J. Clin. 57 1 43 66 17237035 10.3322/canjclin.57.1.43 (Pubitemid 46148091)
8. J.E. Quinn R.D. Kennedy P.B. Mullan P.M. Gilmore M. Carty P.G. Johnston D.P. Harkin 2003 BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis Cancer Res. 63 19 6221 6228 14559807 1:CAS:528:DC%2BD3sXotV2jur0%3D (Pubitemid 37255167)
9. J.E. Quinn C.R. James G.E. Stewart J.M. Mulligan P. White G.K. Chang P.B. Mullan P.G. Johnston R.H. Wilson D.P. Harkin 2007 BRCA1 mRNA expression levels predict for overall survival in ovarian cancer after chemotherapy Clin. Cancer Res. 13 24 7413 7420 18094425 10.1158/1078-0432.CCR-07-1083 1:CAS:528: DC%2BD2sXhsVCktr3J
10. R. Rosell G. Scagliotti K.D. Danenberg R.V. Lord G. Bepler S. Novello J. Cooc L. Crino J.J. Sanchez M. Taron, et al. 2003 Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer Oncogene 22 23 3548 3553 12789263 10.1038/sj.onc.1206419 1:CAS:528:DC%2BD3sXktlSjtrw%3D (Pubitemid 36765314)
11. R. Rosell K.D. Danenberg V. Alberola G. Bepler J.J. Sanchez C. Camps M. Provencio D. Isla M. Taron P. Diz, et al. 2004 Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients Clin. Cancer Res. 10 4 1318 1325 14977831 10.1158/1078-0432.CCR-03-0156 1:CAS:528:DC%2BD2cXhsVCqu7o%3D (Pubitemid 38365223)
12. R. Rosell E. Felip M. Taron J. Majo P. Mendez M. Sanchez-Ronco C. Queralt J.J. Sanchez J. Maestre 2004 Gene expression as a predictive marker of outcome in stage IIB-IIIA-IIIB non-small cell lung cancer after induction gemcitabine-based chemotherapy followed by resectional surgery Clin. Cancer Res. 10 12Pt2 4215s 4219s 15217961 10.1158/1078-0432.CCR-040006 1:CAS:528: DC%2BD2cXltFWlsrw%3D (Pubitemid 38812449)
13. R. Rosell M. Skrzypski E. Jassem M. Taron R. Bartolucci J.J. Sanchez P. Mendez I. Chaib L. Perez-Roca A. Szymanowska, et al. 2007 BRCA1: a novel prognostic factor in resected non-small-cell lung cancer PLoS One 2 11 e1129 17987116 10.1371/journal.pone.0001129 (Pubitemid 351594028)
14. M. Taron R. Rosell E. Felip P. Mendez J. Souglakos M.S. Ronco C. Queralt J. Majo J.M. Sanchez J.J. Sanchez, et al. 2004 BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer Hum. Mol. Genet. 13 20 2443 2449 15317748 10.1093/hmg/ddh260 1:CAS:528:DC%2BD2cXnvVOktLo%3D (Pubitemid 39377848)
15. L.R. Wang X.H. Wu M.Z. Huang J. Cai N. Xu J. Liu 2007 The efficacy and relationship between peak concentration and toxicity profile of fixed-dose-rate gemcitabine plus carboplatin in patients with advanced non-small-cell lung cancer Cancer Chemother. Pharmacol. 60 2 211 218 17124596 10.1007/s00280-006- 0363-x 1:CAS:528:DC%2BD2sXltFSkt7s%3D (Pubitemid 46742536)
16. L.R. Wang M.Z. Huang G.B. Zhang N. Xu X.H. Wu 2007 Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer Cancer Chemother. Pharmacol. 60 4 601 607 17549479 10.1007/s00280-007-0504-x 1:CAS:528:DC%2BD2sXnvFKnsbw%3D (Pubitemid 47084272)